Investing in Cannabis | Live Webinar - Mar. 25, 2021
Email not displaying correctly?
Cannabis By The Numbers
70%+
2 out of 3
46%
15%
25
  U.S. population living in a state where cannabis is legal for either medical or recreational use.
  Number of people in the U.S. that support the legalization of cannabis – 68%, which is an all time high.
  Growth of U.S. sales in legal cannabis last year – from $12.9 billion in 2019 to over $17.5 billion in 2020.
  Compound annual growth rate of U.S. cannabis sales forecast through 2026 – $41.3 billion in 2026.
  Number of states currently considering bills to legalize cannabis in some form.
 The cannabis story isn't only found in the U.S. 
 
 
Source: BDSA. 
Forecasts are inherently limited and should not be relied upon when making investment decisions. There is no guarantee the sector will experience projected growth. In addition, there is no guarantee it will translate to positive fund performance.
 
U.S. cannabis only
 
U.S. & International cannabis
 
MSOS | YOLO — Cannabis Advantages
Multi-State Operator Exposure – Are the only U.S.-listed ETFs offering this exposure.
Opportunistic – Can invest in mid and small cap companies and new cannabis equity IPOs, which may benefit from merger and acquisition activity as the market evolves.
Active Management – Can adjust their portfolios more quickly and opportunistically than a passive index-based strategy, an important attribute in a rapidly evolving marketplace.
Ease of Access with Risk Mitigation – The ETF structure offers access to cannabis by diversifying across multiple securities, rather than just one or two stocks, and in a single trade on the NYSE.
Experienced – Are led by a portfolio manager with deep investing experience in highly regulated industries and partnered with an established, well-regarded custodial bank.
Live Cannabis Webinar
 
Join Us – March 25, 2021
at 4:15 pm EST
 
featuring:
Dan Ahrens
AdvisorShares | PM of MSOS, YOLO
We Know Your Time Is Valuable
We Are Here for You
  An AdvisorShares Investment Consultant can be reached at 1.877.843.3831 to discuss our actively managed ETF offerings. We are able to assist with special order handling to ensure that you receive the best trading execution.
to an ADVISORSHARES Portfolio Manager or Investment Consultant
 

 
Connect with us:
Facebook Twitter LinkedIn
ADVISORSHARES |  1.877.843.3831 | www.advisorshares.com | Electronic mail policy

 
-For Financial Intermediary Use Only - Not For Use With The Retail Public-
 
Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained by visiting the Fund’s website at www.AdvisorShares.com. Please read the prospectus carefully before you invest.  Foreside Fund Services, LLC distributor.
 
The Fund is subject to a number of risks that may affect the value of its shares. This section provides additional information about the Fund’s principal risks. The degree to which a risk applies to the Fund varies according to its investment allocation. Each investor should review the complete description of the principal risks before investing in the Fund. As with investing in other securities whose prices increase and decrease in market value, you may lose money by investing in the Fund.
 
Cannabis-Related Company Risk: Cannabis-related companies are subject to various laws and regulations that may differ at the state/local and federal level. These laws and regulations may (i) significantly affect a cannabis-related company’s ability to secure financing, (ii) impact the market for marijuana industry sales and services, and (iii) set limitations on marijuana use, production, transportation, and storage. Cannabis-related companies may also be required to secure permits and authorizations from government agencies to cultivate or research marijuana. In addition, cannabis-related companies are subject to the risks associated with the greater agricultural industry, including changes to or trends that affect commodity prices, labor costs, weather conditions, and laws and regulations related to environmental protection, health and safety. Cannabis-related companies may also be subject to risks associated with the biotechnology and pharmaceutical industries. These risks include increased government regulation, the use and enforcement of intellectual property rights and patents, technological change and obsolescence, product liability lawsuits, and the risk that research and development may not necessarily lead to commercially successful products.
 

 
 
 
Add alpha@advisorshares.com to your address book to ensure delivery.

ADVISORSHARES

4800 Montgomery Lane, Ste. 150, Bethesda, MD 20814

Unsubscribe - Unsubscribe Preferences